MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. OCUL
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Ocular Therapeutix (OCUL) Revenue & Earnings 2020-2026

Revenue, EBITDA, operating income, net income, EPS, and shares

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$52.04M
12.8%
Q. Revenue
$10.79M
TTM EBITDA
$-291.25M
47.7%
TTM Op. Income
$-299.44M
46.7%
Q. Op. Income
$-93.34M
TTM Net Income
$-290.50M
50.7%
Q. Net Income
$-88.61M
EPS
$-0.4
Shares Out.
$224.10M
32.3%
$52.04M in TTM revenue declined 12.8% YoY, reaching $10.79M last quarter. TTM EBITDA of $-291.25M and TTM operating income of $-299.44M shows growth is flowing through. However, net income is negative at $290.50M — growth is not yet reaching the bottom line. Revenue is contracting — assess whether this is cyclical or structural.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders